To highlight the advancements in keratoconus treatment, particularly through corneal crosslinking technology, and its significance in transforming patient care.
Key Findings:
Corneal crosslinking has significantly reduced the need for full-thickness corneal transplants, with a noted decrease in transplant rates.
Epi-on crosslinking has been recently approved, offering a less invasive option for patients, potentially increasing treatment uptake.
Visual rehabilitation techniques, such as CTAK, are improving patient comfort and outcomes, with specific patient feedback or case studies.
Interpretation:
The advancements in keratoconus management, particularly through crosslinking, are transforming patient care and outcomes, allowing for earlier intervention and better visual rehabilitation, which is crucial for long-term patient satisfaction.
Limitations:
Currently, only 15% to 20% of keratoconus patients who are candidates for crosslinking are receiving treatment, highlighting a significant gap in care.
Ongoing need for improved identification and collaboration to increase treatment rates, including addressing patient awareness and access to care.
Conclusion:
The future of keratoconus management looks promising with ongoing innovations and a focus on early detection and collaborative care, emphasizing the need for continued efforts to increase treatment accessibility.
